Why patients choose weight-loss surgery even when using diabetes-related medications

A subset of patients using glucagon-like peptide-1 receptor agonists considers metabolic and bariatric surgery.

• Patients may choose surgery to enhance weight loss outcomes after initially using glucagon-like peptide-1 receptor agonists.
• Understanding patient motivations could provide insights into their decision-making processes regarding surgical options.
• The popularity of glucagon-like peptide-1 receptor agonists is associated with increased interest in surgical interventions for obesity.

Simplified